SREBF2 and central nervous system cancer: Previous studies have shown that ART can inhibit the nuclear localization of SREBP2 in glioma and can also inhibit the expression of metabolites belonging to the methylvalproic acid (MVA) pathway, such as HMGCR and isopentenyl pyrophosphate (IPP)24, 33, 34.